Are you recommending tocilizumab for any COVID-19 patients?  

Current guidelines do not support its use, but the EMPACTA trial suggests it may be effective in a subpopulation of patients.



Answer from: at Academic Institution
Comments
at UAB
The REMAP-CAP and EMPACTA trials emphasize that th...
at Massachusetts General Hospital
I completely agree, and I anticipate there will be...
Sign in or Register to read more